AK MEDICAL 01789·

Gross margin 65.56%--60.49%5.06%61.66%1.17%60.03%1.63%60.54%0.51% Net margin 12.16%--19.46%7.30%16.65%2.82%20.35%3.70%22.87%2.53% ROE 4.56%--9.13%4.57%7.61%1.51%10.38%2.77%11.64%1.26% ROA 3.56%--7.38%3.83%6.06%1.32%8.21%2.15%9.26%1.05% Revenue growth ----38.17%--3.97%34.19%23.08%19.11%10.11%12.98% Attributable profit growth ----121.09%---11.07%132.16%50.42%61.49%23.79%26.63% Debt-to-assets 22.02%--19.13%2.89%20.35%1.22%20.90%0.55%20.47%0.43% Current ratio 3.95--4.730.783.960.773.650.314.100.45 Operating cash flow / net profit 1.91--1.190.720.191.001.651.461.170.48 Operating cash flow / revenue 23.20%--23.09%0.11%3.10%19.99%33.50%30.40%26.71%6.79%

Gross margin 59.11%--63.74%4.63% Net margin 23.14%--25.72%2.59% Revenue growth ----10.15%-- Attributable profit growth ----22.48%-- Debt-to-assets ----22.25%-- Current ratio ----3.62--

Revenue 761.44M--1.05B38.17%1.09B3.97%1.35B23.08%1.48B10.11% Other income and gains 5.98M--11.19M87.21%26.37M135.59%16.65M36.84%30.09M80.65% Gross profit 499.19M--636.43M27.49%674.49M5.98%808.19M19.82%897.39M11.04% Selling and distribution expenses 187.35M--180.11M3.86%218.81M21.49%240.91M10.10%265.62M10.26% Administrative expenses 105.32M--118.31M12.34%133.44M12.79%143.95M7.87%151.96M5.56% Net finance costs 9.12M--20.31M122.59%------------ Income tax 15.94M--35.52M122.82%49.01M37.99%45.90M6.36%55.88M21.76% Operating profit 99.44M--219.98M121.23%211.48M3.86%300.78M42.22%373.88M24.30% Profit before tax 108.56M--240.29M121.35%231.12M3.82%319.82M38.38%394.98M23.50% Net profit 92.62M--204.77M121.09%182.10M11.07%273.93M50.42%339.09M23.79% Net profit attributable to owners 92.62M--204.77M121.09%182.10M11.07%273.93M50.42%339.09M23.79%

Revenue 694.23M--764.73M10.15% Other income and gains 18.26M--6.14M66.38% Cost of sales 283.89M--277.28M2.33% Gross profit 410.33M--487.44M18.79% Selling and distribution expenses 117.30M--121.20M3.32% Administrative expenses 77.39M--79.29M2.46% Net finance costs 19.46M--9.53M51.05% Income tax 26.06M--33.00M26.63% Operating profit 167.21M--220.19M31.68% Profit before tax 186.67M--229.72M23.06% Net profit 160.61M--196.72M22.48% Net profit attributable to owners 160.61M--196.72M22.48%

Cash and cash equivalents 475.61M--625.83M31.59%331.22M47.08%352.17M6.33%357.23M1.44% Trade and bills receivables 387.99M--467.08M20.38%451.40M3.36%494.82M9.62%627.65M26.85% Inventories 423.07M--402.33M4.90%595.51M48.02%488.67M17.94%459.22M6.03% Total current assets 1.93B--2.07B6.77%1.97B4.38%2.18B10.29%2.70B23.96% Total assets 2.61B--2.77B6.49%3.00B8.24%3.34B11.07%3.66B9.81% Total current liabilities 489.44M--436.38M10.84%498.17M14.16%596.42M19.72%657.94M10.32% Total liabilities 573.73M--530.73M7.50%611.12M15.15%697.21M14.09%749.83M7.55% Equity attributable to owners 2.03B--2.24B10.45%2.39B6.60%2.64B10.30%2.91B10.41% Total equity 2.03B--2.24B10.45%2.39B6.60%2.64B10.30%2.91B10.41%

Cash and cash equivalents ----1.08B-- Trade and bills receivables ----739.72M-- Inventories ----470.37M-- Total current assets ----2.59B-- Total assets ----3.54B-- Total current liabilities ----715.93M-- Total liabilities ----788.01M-- Equity attributable to owners ----2.75B-- Total equity ----2.75B--

Net cash from operating activities 176.62M--242.92M37.54%33.94M86.03%451.07M1229.22%395.98M12.21% Net cash from investing activities -297.10M---82.29M72.30%-318.15M286.60%-393.35M23.64%-304.61M22.56% Net cash from financing activities -100.70M---36.80M63.46%-14.02M61.90%-39.43M181.21%-85.47M116.77% Net change in cash -221.18M--123.83M155.98%-298.23M340.84%18.30M106.14%5.90M67.75%